P3 Health Partners Inc
PIII4.120USD
-0.200-4.63%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
13.46MMarket Cap
LossP/E TTM
More Details of P3 Health Partners Inc Company
P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.
P3 Health Partners Inc Info
Ticker SymbolPIII
Company nameP3 Health Partners Inc
IPO dateFeb 10, 2021
CEOCoffman (Aric)
Number of employees360
Security typeOrdinary Share
Fiscal year-endFeb 10
Address2045 W Grand Ave Ste B
CityCHICAGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code60612-1577
Phone13128228897
Websitehttps://ir.p3hp.org/
Ticker SymbolPIII
IPO dateFeb 10, 2021
CEOCoffman (Aric)
Company Executives of P3 Health Partners Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Amir Bacchus, M.D.
Dr. Amir Bacchus, M.D.
Co-Founder, Chief Medical Officer, Director
Co-Founder, Chief Medical Officer, Director
45.13K
--
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
21.36K
+10.33%
Mr. Mark Alan Thierer
Mr. Mark Alan Thierer
Independent Chairman of the Board
Independent Chairman of the Board
16.85K
+31.13%
Ms. Mary A. Tolan
Ms. Mary A. Tolan
Independent Director
Independent Director
4.17K
+92.34%
Mr. Gregory N. (Greg) Kazarian
Mr. Gregory N. (Greg) Kazarian
Director
Director
4.17K
+92.34%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Independent Director
Independent Director
4.17K
+92.34%
Mr. Lawrence B. (Larry) Leisure
Mr. Lawrence B. (Larry) Leisure
Independent Director
Independent Director
--
--
Mr. Leif Pedersen
Mr. Leif Pedersen
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Aric Coffman, M.D.
Dr. Aric Coffman, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ryan Halstead
Mr. Ryan Halstead
Managing Director
Managing Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Amir Bacchus, M.D.
Dr. Amir Bacchus, M.D.
Co-Founder, Chief Medical Officer, Director
Co-Founder, Chief Medical Officer, Director
45.13K
--
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
21.36K
+10.33%
Mr. Mark Alan Thierer
Mr. Mark Alan Thierer
Independent Chairman of the Board
Independent Chairman of the Board
16.85K
+31.13%
Ms. Mary A. Tolan
Ms. Mary A. Tolan
Independent Director
Independent Director
4.17K
+92.34%
Mr. Gregory N. (Greg) Kazarian
Mr. Gregory N. (Greg) Kazarian
Director
Director
4.17K
+92.34%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Independent Director
Independent Director
4.17K
+92.34%
Revenue Breakdown
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
355.79M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Aug 22
Updated: Fri, Aug 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Chicago Pacific Founders UGP LLC
46.97%
Leavitt Equity Partners II LP
10.84%
Alyeska Investment Group, L.P.
5.50%
The Vanguard Group, Inc.
1.48%
Bacchus (Amir)
1.37%
Other
33.83%
Shareholders
Shareholders
Proportion
Chicago Pacific Founders UGP LLC
46.97%
Leavitt Equity Partners II LP
10.84%
Alyeska Investment Group, L.P.
5.50%
The Vanguard Group, Inc.
1.48%
Bacchus (Amir)
1.37%
Other
33.83%
Shareholder Types
Shareholders
Proportion
Corporation
57.81%
Hedge Fund
5.50%
Individual Investor
4.27%
Investment Advisor
3.52%
Investment Advisor/Hedge Fund
1.78%
Research Firm
0.10%
Other
27.00%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
140
358.16K
10.96%
-476.81K
2025Q2
159
2.39M
73.22%
-351.07K
2025Q1
163
2.40M
73.55%
-322.33K
2024Q4
164
121.70M
75.84%
-21.19M
2024Q3
165
70.21M
46.23%
-6.58M
2024Q2
165
74.96M
49.19%
+19.75M
2024Q1
158
50.37M
43.55%
+5.90M
2023Q4
154
52.28M
45.78%
+2.36M
2023Q3
212
65.33M
71.01%
-13.71M
2023Q2
211
65.78M
73.28%
-11.63M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Chicago Pacific Founders UGP LLC
1.54M
47.23%
--
--
Jun 04, 2025
Leavitt Equity Partners II LP
356.27K
10.9%
+159.49K
+81.05%
May 24, 2024
Alyeska Investment Group, L.P.
180.91K
5.54%
-1.00
-0.00%
Jun 30, 2025
The Vanguard Group, Inc.
38.36K
1.17%
+1.97K
+5.42%
Jun 30, 2025
Bacchus (Amir)
45.13K
1.38%
--
--
Apr 09, 2025
Corient Private Wealth LLC
35.37K
1.08%
-2.04K
-5.44%
Jun 30, 2025
Abdou (Sherif)
32.16K
0.98%
--
--
Apr 09, 2025
EMFO, LLC
28.55K
0.87%
+8.13K
+39.80%
Jun 30, 2024
Trinity Financial Advisors LLC
26.68K
0.82%
+1.18K
+4.62%
Sep 30, 2025
Wasson (Gregory D)
21.36K
0.65%
+2.00K
+10.33%
Aug 06, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
iShares Micro-Cap ETF
Proportion0%
Fidelity Nasdaq Composite Index ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Apr 04, 2025
Merger
50→1
Date
Type
Ratio
Apr 04, 2025
Merger
50→1
FAQs
Who are the top five shareholders of P3 Health Partners Inc?
The top five shareholders of P3 Health Partners Inc are:
Chicago Pacific Founders UGP LLC holds 1.54M shares, accounting for 47.23% of the total shares.
Leavitt Equity Partners II LP holds 356.27K shares, accounting for 10.90% of the total shares.
Alyeska Investment Group, L.P. holds 180.91K shares, accounting for 5.54% of the total shares.
The Vanguard Group, Inc. holds 38.36K shares, accounting for 1.17% of the total shares.
Bacchus (Amir) holds 45.13K shares, accounting for 1.38% of the total shares.
Chicago Pacific Founders UGP LLC holds 1.54M shares, accounting for 47.23% of the total shares.
Leavitt Equity Partners II LP holds 356.27K shares, accounting for 10.90% of the total shares.
Alyeska Investment Group, L.P. holds 180.91K shares, accounting for 5.54% of the total shares.
The Vanguard Group, Inc. holds 38.36K shares, accounting for 1.17% of the total shares.
Bacchus (Amir) holds 45.13K shares, accounting for 1.38% of the total shares.
What are the top three shareholder types of P3 Health Partners Inc?
The top three shareholder types of P3 Health Partners Inc are:
Chicago Pacific Founders UGP LLC
Leavitt Equity Partners II LP
Alyeska Investment Group, L.P.
Chicago Pacific Founders UGP LLC
Leavitt Equity Partners II LP
Alyeska Investment Group, L.P.
How many institutions hold shares of P3 Health Partners Inc (PIII)?
As of 2025Q3, 140 institutions hold shares of P3 Health Partners Inc, with a combined market value of approximately 358.16K, accounting for 10.96% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -62.26%.
What is the biggest source of revenue for P3 Health Partners Inc?
In FY2025Q2, the -- business generated the highest revenue for P3 Health Partners Inc, amounting to -- and accounting for --% of total revenue.
